These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 22202059)
1. Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer. Koizumi K; Kato S; Sakurai H; Hashimoto I; Yasumoto K; Saiki I Front Biosci (Schol Ed); 2012 Jan; 4(1):269-76. PubMed ID: 22202059 [TBL] [Abstract][Full Text] [Related]
2. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Yasumoto K; Koizumi K; Kawashima A; Saitoh Y; Arita Y; Shinohara K; Minami T; Nakayama T; Sakurai H; Takahashi Y; Yoshie O; Saiki I Cancer Res; 2006 Feb; 66(4):2181-7. PubMed ID: 16489019 [TBL] [Abstract][Full Text] [Related]
3. Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Hashimoto I; Koizumi K; Tatematsu M; Minami T; Cho S; Takeno N; Nakashima A; Sakurai H; Saito S; Tsukada K; Saiki I Eur J Cancer; 2008 May; 44(7):1022-9. PubMed ID: 18375114 [TBL] [Abstract][Full Text] [Related]
4. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer. Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma. Xue LJ; Mao XB; Ren LL; Chu XY Cancer Med; 2017 Jun; 6(6):1424-1436. PubMed ID: 28544785 [TBL] [Abstract][Full Text] [Related]
6. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis. Tsuboi K; Kodera Y; Nakanishi H; Ito S; Mochizuki Y; Nakayama G; Koike M; Fujiwara M; Yamamura Y; Nakao A Oncol Rep; 2008 Nov; 20(5):1117-23. PubMed ID: 18949410 [TBL] [Abstract][Full Text] [Related]
7. Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer. Zieker D; Königsrainer I; Tritschler I; Löffler M; Beckert S; Traub F; Nieselt K; Bühler S; Weller M; Gaedcke J; Taichman RS; Northoff H; Brücher BL; Königsrainer A Int J Cancer; 2010 Mar; 126(6):1513-20. PubMed ID: 19688824 [TBL] [Abstract][Full Text] [Related]
8. The role of the CXCR4/CXCL12 axis and its clinical implications in gastric cancer. Lee HJ; Jo DY Histol Histopathol; 2012 Sep; 27(9):1155-61. PubMed ID: 22806902 [TBL] [Abstract][Full Text] [Related]
9. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer. Masuda T; Nakashima Y; Ando K; Yoshinaga K; Saeki H; Oki E; Morita M; Oda Y; Maehara Y Anticancer Res; 2014 Nov; 34(11):6397-403. PubMed ID: 25368239 [TBL] [Abstract][Full Text] [Related]
10. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. Zhao BC; Wang ZJ; Mao WZ; Ma HC; Han JG; Zhao B; Xu HM World J Gastroenterol; 2011 May; 17(19):2389-96. PubMed ID: 21633638 [TBL] [Abstract][Full Text] [Related]
11. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer. Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells. Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890 [TBL] [Abstract][Full Text] [Related]
13. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Kajiyama H; Shibata K; Terauchi M; Ino K; Nawa A; Kikkawa F Int J Cancer; 2008 Jan; 122(1):91-9. PubMed ID: 17893878 [TBL] [Abstract][Full Text] [Related]
14. Peritoneal Dissemination Requires an Sp1-Dependent CXCR4/CXCL12 Signaling Axis and Extracellular Matrix-Directed Spheroid Formation. Kasagi Y; Harada Y; Morodomi Y; Iwai T; Saito S; Yoshida K; Oki E; Saeki H; Ohgaki K; Sugiyama M; Onimaru M; Maehara Y; Yonemitsu Y Cancer Res; 2016 Jan; 76(2):347-57. PubMed ID: 26744523 [TBL] [Abstract][Full Text] [Related]
15. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies. Khare T; Bissonnette M; Khare S Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991 [TBL] [Abstract][Full Text] [Related]
16. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention. Zheng N; Chen J; Li T; Liu W; Liu J; Chen H; Wang J; Jia L Mol Carcinog; 2017 Aug; 56(8):1896-1908. PubMed ID: 28277622 [TBL] [Abstract][Full Text] [Related]
17. LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis. Dong XZ; Zhao ZR; Hu Y; Lu YP; Liu P; Zhang L Gastric Cancer; 2020 Mar; 23(2):260-272. PubMed ID: 31650323 [TBL] [Abstract][Full Text] [Related]
18. Dual blockade of MET and VEGFR2 signaling pathways as a potential therapeutic maneuver for peritoneal carcinomatosis in scirrhous gastric cancer. Kasai S; Kuwayama N; Motoo Y; Kawashima A; Matsumoto K; Yano S; Matsushima K; Yasumoto K Biochem Biophys Res Commun; 2022 Apr; 600():80-86. PubMed ID: 35196631 [TBL] [Abstract][Full Text] [Related]